l-Serine links metabolism with neurotransmission

Autor: Pierre-Antoine Vigneron, Marianne Maugard, Gilles Bonvento, Juan P. Bolaños
Přispěvatelé: Agence Nationale de la Recherche (France), French National Foundation on Alzheimer’s Disease and Related Disorders, Fondation pour la Recherche Médicale, Instituto de Salud Carlos III, Ministerio de Ciencia, Innovación y Universidades (España), Agencia Estatal de Investigación (España), Junta de Castilla y León, Fundación Ramón Areces, Fundación BBVA
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: Digital.CSIC. Repositorio Institucional del CSIC
instname
ISSN: 2017-0637
Popis: Brain energy metabolism is often considered as a succession of biochemical steps that metabolize the fuel (glucose and oxygen) for the unique purpose of providing sufficient ATP to maintain the huge information processing power of the brain. However, a significant fraction (10–15 %) of glucose is shunted away from the ATP-producing pathway (oxidative phosphorylation) and may be used to support other functions. Recent studies have pointed to the marked compartmentation of energy metabolic pathways between neurons and glial cells. Here, we focused our attention on the biosynthesis of l-serine, a non-essential amino acid that is formed exclusively in glial cells (mostly astrocytes) by re-routing the metabolic fate of the glycolytic intermediate, 3-phosphoglycerate (3PG). This metabolic pathway is called the phosphorylated pathway and transforms 3PG into l-serine via three enzymatic reactions. We first compiled the available data on the mechanisms that regulate the flux through this metabolic pathway. We then reviewed the current evidence that is beginning to unravel the roles of l-serine both in the healthy and diseased brain, leading to the notion that this specific metabolic pathway connects glial metabolism with synaptic activity and plasticity. We finally suggest that restoring astrocyte-mediated l-serine homeostasis may provide new therapeutic strategies for brain disorders.
This work was supported by grants from the Agence Nationale de la Recherche (ANR 2011MALZ-0003 to GB), Association France Alzheimer and Fondation de France (Prix Spécial 2012 to GB), Fondation Plan Alzheimer (GB), Infrastructure de Recherche translationnelle pour les Biothérapies en Neurosciences-NeurATRIS ANR-11-INBS-0011 (GB). PAV is a recipient of a PhD fellowship from the Fondation pour la Recherche Médicale (FRM grant number ECO20170637547). Juan P. Bolanos is funded by MCINU (PID2019-105699RB-I00/ AEI / 10.13039/501100011033 and RED2018-102576-T), Instituto de Salud Carlos III (RD12/0043/0021), Junta de Castilla y León (Escalera de Excelencia CLU-2017-03), Ayudas Equipos Investigación Biomedicina 2017 Fundación BBVA, and Fundación Ramón Areces.
Databáze: OpenAIRE